<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Senior-Health/Fitness.html">
<title>Fitness RSS : Gourt</title>
<link>http://www.gourt.com/Health/Senior-Health/Fitness.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-07-04T16:56+35:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Fitness RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/156052.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/156014.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155718.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155690.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155570.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155556.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155588.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155511.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/155216.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154919.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154920.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154602.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154539.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154489.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/154226.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153824.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153657.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153549.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153404.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153407.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153207.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/153084.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/152769.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/152794.php" />
  <rdf:li rdf:resource="http://www.medicalnewstoday.com/articles/152557.php" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://www.medicalnewstoday.com/articles/156052.php">
<title>Parkinson&#x27;s Disease Alters Patient&#x27;s Ability To Learn From Rewards While Treatment Affects Ability To Learn From Negative Outcomes</title>
<link>http://www.medicalnewstoday.com/articles/156052.php</link>
<description><![CDATA[A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make. The test was developed by Dr. Mark Gluck, professor of neuroscience at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, working with co-researchers at Rutgers, New York University, and in Hungary.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/156014.php">
<title>Discovery Of Neural Stem Cell Differentiation Factor</title>
<link>http://www.medicalnewstoday.com/articles/156014.php</link>
<description><![CDATA[Neural stem cells represent the cellular backup of our brain. These cells are capable of self-renewal to form new stem cells or differentiate into neurons, astrocytes or oligodendrocytes. Astrocytes have supportive functions in the environment of neurons, while oligodendrocytes form the myelin layer around axons in order to accelerate neuronal signal transmission.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155718.php">
<title>Neupro(R) (rotigotine Transdermal Patch) Can Now Be Prescribed To All Patients With Idiopathic Parkinson&#x27;s Disease In Europe</title>
<link>http://www.medicalnewstoday.com/articles/155718.php</link>
<description><![CDATA[UCB announced that Neupro(R) (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155690.php">
<title>UCB Brings Neupro(R) Back To All Patients In Europe</title>
<link>http://www.medicalnewstoday.com/articles/155690.php</link>
<description><![CDATA[ UCB announced that Neupro® (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155570.php">
<title>European Scientific Committee Positive Recommendation From  For A New Once Daily Mirapexin(R) Formulation For The Treatment Of Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/155570.php</link>
<description><![CDATA[ Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin®/ Sifrol® (pramipexole), in all countries of the European Union, Norway, Iceland and Liechtenstein.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155556.php">
<title>UT Gets Federal Stimulus Grant For Parkinson&#x27;s Disease Research</title>
<link>http://www.medicalnewstoday.com/articles/155556.php</link>
<description><![CDATA[  The University of Texas Health Science Center at Houston has received a $412,500 federal stimulus grant for Parkinson's disease research, the university announced today. It is the university's first federal stimulus grant.    Parkinson's disease is an incurable brain disorder. Its symptoms include trembling, stiffness and problems with balance. An estimated one million Americans are diagnosed with the neurological disorder.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155588.php">
<title>Enzyme Fights Mutated Protein In Inherited Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/155588.php</link>
<description><![CDATA[An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson's disease, researchers at UT Southwestern Medical Center have found.    Their study, using human cells, provides a focus for further research into halting the action of the mutated protein. One of the most famous carriers of the mutation is Google co-founder Sergey Brin, who wrote about it on his blog in 2008.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155511.php">
<title>Enzyme Fights Mutated Protein In Inherited Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/155511.php</link>
<description><![CDATA[ An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson's disease, researchers at UT Southwestern Medical Center have found.   Their study, using human cells, provides a focus for further research into halting the action of the mutated protein. One of the most famous carriers of the mutation is Google co-founder Sergey Brin, who wrote about it on his blog in 2008.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/155216.php">
<title>Mouse Model Of Parkinson&#x27;s Reproduces Nonmotor Symptoms</title>
<link>http://www.medicalnewstoday.com/articles/155216.php</link>
<description><![CDATA[  The classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. Over the last decade, neurologists have been paying greater attention to non-motor symptoms, such as digestive and sleep problems, loss of sense of smell and depression.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154919.php">
<title>More Attention To Non-motor Manifestations Of Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/154919.php</link>
<description><![CDATA[An important problem of patients with PD is not related to dopamine deficit. "PD patients suffer not only of motor but also of such non-motor disturbances as sleep disturbances, depression, psychosis, hallucinations or dementia. These disturbances require a precise diagnostic work up and specific, usually non dopaminergic medications."  A whole series of studies being presented at the ENS meeting are devoted to this problem area.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154920.php">
<title>Parkinson&#x27;s Disease As A Risk Factor For Compulsive Gambling And Impulse Control Disorders</title>
<link>http://www.medicalnewstoday.com/articles/154920.php</link>
<description><![CDATA[There is also increasing knowledge about higher frequency of compulsive behavior in patients with PD compared to the general population. "These impulse control disorders such as pathological gambling, hyper-sexuality, compulsive shopping, compulsive eating or compulsive overuse of dopaminergic drugs can lead to monetary losses or worsen social handicap of PD patients," Professor Bassetti explains.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154602.php">
<title>Announcing National MS And Parkinson&#x27;s Disease Registries Act</title>
<link>http://www.medicalnewstoday.com/articles/154602.php</link>
<description><![CDATA[Senator Byron Dorgan (ND) on Tuesday introduced legislation that would for the first time establish a national coordinated system to collect and analyze data on multiple sclerosis and Parkinson's disease. Accurate incidence and prevalence information on these two diseases currently does not exist. Click here to ask your Senator to support this legislation.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154539.php">
<title>NIH Resources Grant Extended For The National Resource For Aplysia</title>
<link>http://www.medicalnewstoday.com/articles/154539.php</link>
<description><![CDATA[  The National Resource for Aplysia at the University of Miami's Rosenstiel School of Marine & Atmospheric Science has had its resources grant with the National Institute for Health (NIH) extended for an additional five years. The National Resource for Aplysia is the only facility in the world that cultures and raises Aplysia californica, commonly known as sea hares or sea slugs. Over the course of the next five years, the facility will receive $2.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154489.php">
<title>Parkinson&#x27;s Disease Society Joins Forces With Healthy Interactions To Launch New Education Programme</title>
<link>http://www.medicalnewstoday.com/articles/154489.php</link>
<description><![CDATA[ As part of a Europe-wide drive to improve access to information and education for people with Parkinson's Disease, the Parkinson's Disease Society (PDS) is launching a new education initiative with American company, Healthy Interactions.   The Conversation Map™ tools will address the needs of people at all stages of Parkinson's and those of their families and carers.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/154226.php">
<title>All Party Parliamentary Group For Parkinson&#x27;s Disease Announces Report &#x26; Parkinson&#x27;s Disease Society Launches Fair Care For Parkinson&#x27;s</title>
<link>http://www.medicalnewstoday.com/articles/154226.php</link>
<description><![CDATA[When:           8 July 2009 6:00pm - 8:00pm   What:           Launch of the APPG's report into inequalities of access to services for people with Parkinson's and their carers.                   In response to the report, the Parkinson's Disease Society will also launch Fair Care for Parkinson's, calling for the Government to ensure the APPG report recommendations are carried out.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153824.php">
<title>A Research Group Focus On Neurobiology Of Parkinson&#x27;s Disease An The Early Detection Of The Disease</title>
<link>http://www.medicalnewstoday.com/articles/153824.php</link>
<description><![CDATA[A research group based at the University of Granada, in cooperation with the Neurology Unit of the San Cecilio Hospital of Granada and the Department of Experimental Sciences of the University of Jaen, is studying the Neurobiology of Parkinson's disease (PD). They have developed a non-invasive method for serological diagnosis of Parkinson's disease, which is being patented by the University of Granada.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153657.php">
<title>Parkinson&#x27;s Treatment May Be Enhanced By Wii-Hab</title>
<link>http://www.medicalnewstoday.com/articles/153657.php</link>
<description><![CDATA[The Nintendo Wii may help treat symptoms of Parkinson's disease, including depression, a Medical College of Georgia researcher says.    Parkinson's disease is a degenerative disease that impairs motor skills. Dr. Herz theorized that the popular computer game console, which simulates various sports and activities, could improve coordination, reflexes and other movement-related skills, but he found additional benefits as well.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153549.php">
<title>New Data Shows Requip-Modutab Improves Nocturnal Symptoms In Patients With Advanced Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/153549.php</link>
<description><![CDATA[ New data presented at the 13th International Congress of Parkinson's Disease and Movement Disorders show that Requip-Modutab* (ropinirole prolonged release tablets) improves nocturnal symptoms experienced by patients with advanced Parkinson's disease (PD).[i] The data showed that patients with more significant nocturnal symptoms had a greater improvement with Requip-Modutab, when used as an adjunct to levodopa (L-dopa), versus placebo.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153404.php">
<title>Mice With Parkinson&#x27;s Disease Gene May Point The Way To New Treatments</title>
<link>http://www.medicalnewstoday.com/articles/153404.php</link>
<description><![CDATA[ Scientists at Weill Cornell Medical College have developed a new mouse model of Parkinson's disease (PD) that successfully reproduces the impairments of movement and the degenerative brain changes that occur in the human disease. Their research, performed in collaboration with investigators at Columbia University Medical Center, appears in the June 7 issue of the journal Nature Neuroscience.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153407.php">
<title>EPDA Life With Parkinson&#x27;s Campaign Launches In Ten Languages To Improve Knowledge Of Parkinson&#x27;s Disease Across Europe</title>
<link>http://www.medicalnewstoday.com/articles/153407.php</link>
<description><![CDATA[    The European Parkinson's Disease Association (EPDA) announces   the launch today of multiple language versions of its pan-European awareness   campaign, Life with Parkinson's at the International Congress of Parkinson's   Disease and Movement Disorders.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153207.php">
<title>Clinical Pharmacology Study With AZILECT(R) (Rasagiline Tablets) Demonstrated It Does Not Increase Tyramine Sensitivity</title>
<link>http://www.medicalnewstoday.com/articles/153207.php</link>
<description><![CDATA[Teva Neuroscience, Inc. presented results from a clinical pharmacology study in which AZILECT(R) (rasagiline tablets) did not increase the risk of tyramine sensitivity at the maximum approved dose of 1 mg. The presentation was made during the 13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/153084.php">
<title>St. Jude Medical Completes Implants In U.S. Study Of Deep Brain Stimulation For Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/153084.php</link>
<description><![CDATA[St. Jude Medical, Inc. (NYSE:STJ) announced the completion of patient implants in its U.S. pivotal clinical study of deep brain stimulation (DBS) for the symptomatic treatment of Parkinson's disease, a neurological disorder affecting approximately 6.3 million people worldwide that progressively diminishes a person's control over his or her movements.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/152769.php">
<title>IMEC, VIB And K.U.Leuven Launch Pioneering Brain Research</title>
<link>http://www.medicalnewstoday.com/articles/152769.php</link>
<description><![CDATA[ IMEC, Europe's leading independent     nanoelectronics research center, VIB, Flanders' leading life science     institute, and the Leuven University, K.U.Leuven, set up a joint basic     research initiative to unravel the neuronal circuitry of the human     brain: Neuroelectronics Research Flanders (NERF).]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/152794.php">
<title>Parkinson&#x27;s Disease Associated With Pesticide Exposure In French Farm Workers</title>
<link>http://www.medicalnewstoday.com/articles/152794.php</link>
<description><![CDATA[The cause of Parkinson's disease (PD), the second most frequent neurodegenerative disease after Alzheimer's disease, is unknown, but in most cases it is believed to involve a combination of environmental risk factors and genetic susceptibility.]]></description>
</item>

<item rdf:about="http://www.medicalnewstoday.com/articles/152557.php">
<title>Researchers At The University Of Tennessee Health Science Center Begin New Study On Parkinson&#x27;s Disease</title>
<link>http://www.medicalnewstoday.com/articles/152557.php</link>
<description><![CDATA[ Researchers at the University of Tennessee Health Science Center (UTHSC) are recruiting participants for a national clinical study of medication that could slow the progression of Parkinson's disease.  The study, referred to as "QE3," will examine the effectiveness of the research medication Coenzyme Q10 (CoQ).]]></description>
</item>

</rdf:RDF>